Molecular Partners AG (MOLN) stock
MOLNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 12, 2026Score 1/30
$2.86+0.16 (+5.98%)
Close on Nov 17, 2026Market cap $115.47MP/E –Yield –
Molecular Partners pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Molecular Partners's pe ratio was 1.1× on Feb 29, 2024.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Feb 29, 2024 | 1.1× | +0.1 |
| 2023 | Dec 29, 2023 | 1.0× | – |
See a number that looks wrong?